BFKN’s Corporate & Securities Group served as legal counsel to Elevate Beauty, an L Catterton platform, in connection with its investment in Eighth Day Skin, a luxury skincare brand that formulates products using bioidentical ingredients to support optimal skin health and beauty.
Launched exclusively at Violet Grey in 2021 by board-certified dermatologist and micrographic reconstructive skin cancer surgeon Dr. Antony Nakhla, Eighth Day made waves in the luxury skincare market with its proprietary skincare innovation, Peptide-Rich Plasma. Inspired by the innate healing and regenerative powers of human skin, Peptide-Rich Plasma is a patent-pending technology composed of 24 bioidentical peptides, growth factors, and amino acids that deliver potent benefits to the skin.
“Eighth Day has established itself as a beloved brand with cult products that harness the power of sophisticated, modern skin technology to promote timeless beauty. The brand has generated tremendous consumer loyalty by offering a narrow lineup of high-performance products that deliver real results,” said Jon Owsley, a managing partner in L Catterton’s Growth Fund.
BFKN's legal team was led by partners Andrew R. Grossmann and Megan Ratia and associate Victoria Rusanova Cordiak.
To read more about this deal, visit: